These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Author: Albertazzi A, Capelli P, Di Paolo B, Pola P, Tondi P, Vaccario O.
    Journal: Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245.
    Abstract:
    Twenty-three patients on regular dialysis treatment (RDT) were given 1-carnitine orally or in dialysate for six months. All patients remained in a stable biochemical state; hyperlipidaemia was reduced with an increase in HDL-cholesterol. Hormonal pattern was unmodified. Serum and muscle carnitine and acetylcarnitine constantly increased. L-carnitine in RDT, by restoring tissue reserves, improves metabolic alterations without any side-effects.
    [Abstract] [Full Text] [Related] [New Search]